Literature DB >> 3384479

Biomonitoring of aromatic amines and alkylating agents by measuring hemoglobin adducts.

H G Neumann1.   

Abstract

Analysis of hemoglobin adducts in blood samples is suitable for the biological monitoring of genotoxic chemicals. The method is specific because the compound to which the individual was exposed is identified. The sensitivity of the method depends on the analytical procedure applied, but is hardly limiting since large amounts of the protein can be obtained. The method provides not only information about the internal exposure to the environmental chemical, but also about the individual's capacity to generate ultimate genotoxic metabolites from it. Since macromolecular damage in blood cells is correlated to that in potential target tissues, this information is relevant to risk assessment, insofar as macromolecular damage produced by a specific chemical can be correlated with the development of tumors.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3384479     DOI: 10.1007/bf00378690

Source DB:  PubMed          Journal:  Int Arch Occup Environ Health        ISSN: 0340-0131            Impact factor:   3.015


  24 in total

1.  Evaluation of genetic risks of alkylating agents IV. Quantitative determination of alkylated amino acids in haemoglobin as a measure of the dose after-treatment of mice with methyl methanesulfonate.

Authors:  D Segerbäck; C J Calleman; L Ehrenberg; G Löfroth; S Osterman-Golkar
Journal:  Mutat Res       Date:  1978-01       Impact factor: 2.433

2.  Evaluation of genetic risks of alkylating agents: tissue doses in the mouse from air contaminated with ethylene oxide.

Authors:  L Ehrenberg; K D Hiesche; S Osterman-Golkar; I Wenneberg
Journal:  Mutat Res       Date:  1974-08       Impact factor: 2.433

Review 3.  The metabolic activation of carcinogenic aromatic amines and amides.

Authors:  J A Miller; E C Miller
Journal:  Prog Exp Tumor Res       Date:  1969

Review 4.  The role of DNA damage in chemical carcinogenesis of aromatic amines.

Authors:  H G Neumann
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

5.  Binding of chemical carcinogens and mutagens to rat hemoglobin.

Authors:  M A Pereira; L W Chang
Journal:  Chem Biol Interact       Date:  1981-01       Impact factor: 5.192

6.  The dose-dependence of DNA interactions of aminostilbene derivatives and other chemical carcinogens.

Authors:  H G Neuman
Journal:  Dev Toxicol Environ Sci       Date:  1983

7.  Relationships between ethylation of hemoglobin, ethylation of DNA and administered amount of ethyl methanesulfonate in the mouse.

Authors:  M S Murthy; C J Calleman; S Osterman-Golkar; D Segerbäck; K Svensson
Journal:  Mutat Res       Date:  1984-06       Impact factor: 2.433

8.  In vivo dosimetry of 4-aminobiphenyl in rats via a cysteine adduct in hemoglobin.

Authors:  L C Green; P L Skipper; R J Turesky; M S Bryant; S R Tannenbaum
Journal:  Cancer Res       Date:  1984-10       Impact factor: 12.701

9.  Biomonitoring of aniline and nitrobenzene. Hemoglobin binding in rats and analysis of adducts.

Authors:  W Albrecht; H G Neumann
Journal:  Arch Toxicol       Date:  1985-04       Impact factor: 5.153

10.  Dosimetry of ethylene oxide in the rat by quantitation of alkylated histidine in hemoglobin.

Authors:  S Osterman-Golkar; P B Farmer; D Segerbäck; E Bailey; C J Calleman; K Svensson; L Ehrenberg
Journal:  Teratog Carcinog Mutagen       Date:  1983
View more
  14 in total

1.  Mass spectrometric characterization of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine N-oxidized metabolites bound at Cys34 of human serum albumin.

Authors:  Lijuan Peng; Robert J Turesky
Journal:  Chem Res Toxicol       Date:  2011-10-04       Impact factor: 3.739

2.  Biomonitoring of aromatic amines II: Hemoglobin binding of some monocyclic aromatic amines.

Authors:  G Birner; H G Neumann
Journal:  Arch Toxicol       Date:  1988       Impact factor: 5.153

Review 3.  Metabolism and biomarkers of heterocyclic aromatic amines in molecular epidemiology studies: lessons learned from aromatic amines.

Authors:  Robert J Turesky; Loic Le Marchand
Journal:  Chem Res Toxicol       Date:  2011-06-20       Impact factor: 3.739

4.  Reduction of aromatic and heterocyclic aromatic N-hydroxylamines by human cytochrome P450 2S1.

Authors:  Kai Wang; F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2013-05-29       Impact factor: 3.739

5.  Monitoring of exposure to styrene oxide by GC-MS analysis of phenylhydroxyethyl esters in hemoglobin.

Authors:  O Sepai; D Anderson; B Street; I Bird; P B Farmer; E Bailey
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153

6.  Monitoring exposure to simple epoxides and alkenes through gas chromatographic determination of hemoglobin adducts.

Authors:  A Kautiainen; M Törnqvist
Journal:  Int Arch Occup Environ Health       Date:  1991       Impact factor: 3.015

7.  Biomonitoring of 4,4'-methylene dianiline by measurement in hydrolysed urine and plasma after epicutaneous exposure in humans.

Authors:  P Brunmark; M Bruze; S Skerfving; G Skarping
Journal:  Int Arch Occup Environ Health       Date:  1995       Impact factor: 3.015

8.  Methemoglobin Formation and Characterization of Hemoglobin Adducts of Carcinogenic Aromatic Amines and Heterocyclic Aromatic Amines.

Authors:  Khyatiben V Pathak; Ting-Lan Chiu; Elizabeth Ambrose Amin; Robert J Turesky
Journal:  Chem Res Toxicol       Date:  2016-02-22       Impact factor: 3.739

9.  Product ion studies of diastereomeric benzo[ghi]fluoranthene tetraols by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and post-source decay.

Authors:  D M Huffer; H F Chang; B P Cho; L K Zhang; M P Chiarelli
Journal:  J Am Soc Mass Spectrom       Date:  2001-04       Impact factor: 3.262

10.  Optimizing proteolytic digestion conditions for the analysis of serum albumin adducts of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, a potential human carcinogen formed in cooked meat.

Authors:  Lijuan Peng; Robert J Turesky
Journal:  J Proteomics       Date:  2014-03-31       Impact factor: 4.044

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.